SCHEMBL7877876

SCHEMBL7877876

CNC(N)=NC(=O)c1cc2c(OC)cc(OCCN(C)C)cc2[nH]1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 1/20 0.42
DRD2 P14416 2/20 0.40
DRD3 P35462 2/20 0.40
HRH3 Q9Y5N1 1/20 0.40
KMT2A Q03164 4/20 0.39
MEN1 O00255 3/20 0.39
POLB P06746 2/20 0.39
KDM4E B2RXH2 2/20 0.39
MAPT P10636 2/20 0.39
HDAC3 O15379 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC7 Q8WUI4 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC10 Q969S8 1/20 0.39
HDAC11 Q96DB2 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
HDAC9 Q9UKV0 1/20 0.39
HDAC5 Q9UQL6 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7878071 0.95 HDAC3 (0.40) FLT3DRD2DRD3HRH3KMT2A
Hydrochloric Acid SCHEMBL7881381 0.94 HDAC3 (0.39) FLT3DRD2DRD3HRH3KMT2A
SCHEMBL7880968 0.90 KMT2A (0.40) FLT3HRH3KMT2AMEN1POLB
SCHEMBL7880066 0.89 ULK1 (0.48) FLT3DRD2DRD3HRH3KMT2A
SCHEMBL7881025 0.89 KMT2A (0.41) DRD2DRD3KMT2AMEN1POLB
SCHEMBL7873365 0.88 HDAC3 (0.42) DRD2DRD3KMT2AMEN1POLB
SCHEMBL7884516 0.87 KMT2A (0.40) KMT2AMEN1POLBKDM4EMAPT
Hydrochloric Acid SCHEMBL7881226 0.87 HDAC3 (0.41) DRD2DRD3KMT2AMEN1POLB
Hydrochloric Acid SCHEMBL7879504 0.86 FLT3 (0.38) FLT3HRH3KDM4EMAPTPDGFRB
SCHEMBL7879479 0.85 FLT3 (0.37) FLT3DRD2DRD3HRH3MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
EP-0622356-B1 Indoloylguanidine derivatives as inhibitors of sodium-hydrogen exchange SUMITOMO PHARMA (JP) 1998-07-01 EP disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed
EP-0622356-A1 Indoloylguanidine derivatives as inhibitors of sodium-hydrogen exchange SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1994-11-02 EP disclosed